Sacubitril 24 mg + Valsartan 26 mg Tablets are an advanced combination therapy widely used for the management of chronic heart failure. This formulation works by improving heart function, reducing strain on the cardiovascular system, and enhancing overall quality of life. Designed to offer dual-action benefits, this combination is preferred in modern cardiac care for its effectiveness in reducing symptoms and minimizing the risk of hospitalization in heart failure patients.
Sacubitril (24 mg): A neprilysin inhibitor that increases the levels of beneficial peptides in the body. This helps relax blood vessels, reduce sodium and fluid retention, and improve overall heart efficiency.
Valsartan (26 mg): An angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and decreases the workload on the heart. Together with Sacubitril, it provides a synergistic effect in managing heart failure.
Take the tablet as prescribed by your cardiologist. Swallow whole with water and avoid altering the dose without medical advice. Regular monitoring of blood pressure and kidney function is recommended.
Some patients may experience dizziness, low blood pressure, cough, or elevated potassium levels. Seek medical attention if symptoms persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Sacubitril 24 mg + Valsartan 26 mg sourced from reputed pharmaceutical manufacturers. Vadasac-50 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.